FDA restricts access to Avandia, cites increased cardiovascular risks - - Drug Topics

Links shared publicly online about this topic.

  • 814
    total visits

FDA restricts access to Avandia, cites increased cardiovascular risks - - Drug Topics

drugtopics.modernmedicine.com

FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.

View full resource at drugtopics.modernmedicine.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Drug, FDA, Avandia, Avandamet, Avandaryl

  • Share

Most Recently Shared on October 9, 2010 at 2:59 pm By:

Diabetes_Type2 Diabetes, Type 2

FDA restricts access to Avandia, cites increased cardiovascular risks: FDA has determined to significantly restric... http://bit.ly/btJ26f

2 years ago...

FDA restricts access to Avandia, cites increased cardiovascular risks - - Drug Topics

drugtopics.modernmedicine.com — “FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 3:08 pm By:

EndocrinologyOW Endocrinology Wisdom OW Health

FDA restricts access to Avandia, cites increased cardiovascular risks: FDA has determined to significantly restric... http://bit.ly/c3pNkN

2 years ago...

Advertisement